Back Up the Truck on ARKG + DNA Tech Bonus Buys
Some investors are worried about money leaving the ARK Genomic Revolution ETF (NYSE: ARKG), but I think it’s a perfect buying opportunity.
Posted by Adam O'Dell | Apr 1, 2021 | Investing
Some investors are worried about money leaving the ARK Genomic Revolution ETF (NYSE: ARKG), but I think it’s a perfect buying opportunity.
Posted by Adam O'Dell | Mar 26, 2021 | Investing
PotlatchDeltic Corp. (Nasdaq: PCH), a lumber supplier and manufacturer, is a stock to buy as the real estate market surges higher in the U.S.
Posted by Adam O'Dell | Mar 25, 2021 | Investing
The future of health care lies in how we use DNA, and the Ark Genomic Revolution ETF (NYSE: ARKG) is a great way to invest in it today.
Posted by Adam O'Dell | Mar 22, 2021 | Investing
In this sneak preview of Ask Adam Anything, I tell you why TransOcean Ltd. (NYSE: RIG) is a contrarian play on the bullish energy sector.
Posted by Adam O'Dell | Mar 20, 2021 | Investing
POSCO is the world’s fourth-largest steel manufacturer, and its stock is a buy now as commodity prices remain at dirt-cheap levels.
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below